Individualized Targeting and Neuromodulation of Late-Life Depression
NCT: NCT04543773 · ACTIVE_NOT_RECRUITING
NCT IDNCT04543773
StatusACTIVE_NOT_RECRUITING
Start Date2024-10-01
Completion2026-09-01
SponsorUniversity of New Mexico (OTHER)
First posted
Last updated
Brief Summary
An open-label, single-arm, clinical research study about how to make transcranial magnetic stimulation (TMS), an FDA-approved treatment, more effective for patients with late-life depression using fMRI.
Frequently Asked Questions
What is Individualized Targeting and Neuromodulation of Late-Life Depression?
Individualized Targeting and Neuromodulation of Late-Life Depression is a clinical trial registered under NCT04543773. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT04543773?
The current status of NCT04543773 (Individualized Targeting and Neuromodulation of Late-Life Depression) is: ACTIVE_NOT_RECRUITING.
When did Individualized Targeting and Neuromodulation of Late-Life Depression start?
Individualized Targeting and Neuromodulation of Late-Life Depression started on 2024-10-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.